Translate this page into:
Evaluation Of-astemizole- A New H-1 Blocking Antihistamine in Urticaria
|How to cite this article:
Pasricha J S, Dashore A, Arya R K. Evaluation Of-astemizole- A New H-1 Blocking Antihistamine in Urticaria. Indian J Dermatol Venereol Leprol 1988;54:27-29
AbstractAn open trial of astemizole a new anthistamine on 30 patients, having urticaria revealed complete relief in 28 patients. The controlling daily dose was 10 mg in 17 patients, 20 mg in 7 and 30 mg in 4. Two patients did not improve even with 40 mg a day given for 7 days. The side effects included mild sedation in 7, dryness of mouth in 3 and constipation in 2 on a dose of 20 or 30 mg a day. Laboratory parameters remained almost normal.